Overview

Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

Status:
Unknown status

Trial end date:
2018-04-01

Target enrollment:

Participant gender:

Summary

Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis. This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11

Phase:

Phase 2

Details

Lead Sponsor:

Seoul National University Hospital

Treatments:

Infliximab
Tumor Necrosis Factor Inhibitors